BRD4 inhibitors (ConverGene)

N/A

Report date: 2025/01/26 17:26:21
NME

Base Information

Drug NameBRD4 inhibitors (ConverGene)
Drug Alias NameCN-427
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 degraders
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConverGene LLC
China Registration ClassN/A

Develop Information

Active CompaniesConverGene LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A